Tirzepatide Side Effects: What's Normal, What's Not, and How to Manage Them
Tirzepatide's dosing schedule is one of the most important aspects of treatment that patients need to understand before starting the medication.
By Arbor Health Team
Dosing schedules, side effects, plateaus, and what happens after the last injection. Every article written and reviewed by Arbor’s medical team.

150 articles, page 5 of 13
Newest first

Tirzepatide's dosing schedule is one of the most important aspects of treatment that patients need to understand before starting the medication.
By Arbor Health Team

Liraglutide was the first GLP-1 receptor agonist approved specifically for weight management, reaching the market as Saxenda in 2014, several years before semaglutide (Wegovy) or tirzepatide (Zepbound) became available.
By Arbor Health Team

For the estimated 37 million Americans living with type 2 diabetes, the relationship between blood sugar management and weight loss has always been frustratingly circular: excess weight drives insulin resistance, insulin resistance makes weight loss harder, and many diabetes medications actually cause weight gain as a side effect.
By Arbor Health Team

"How much weight will I lose?" is the first question most patients ask when considering tirzepatide, and it deserves a thorough, evidence-based answer.
By Arbor Health Team

Tirzepatide's dosing schedule is one of the most important aspects of treatment that patients need to understand before starting the medication.
By Arbor Health Team

You've been taking Contrave for months. The cravings quieted down, the scale moved in the right direction, and for the first time in a long time, food stopped running your day.
By Arbor Health Team

Tirzepatide is the first medication in its class to target two incretin hormones simultaneously - GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).
By Arbor Health Team

Standing on the bathroom scale tells you a number, but that number rarely tells the full story about your health.
By Arbor Health Team

You've seen the ads promising transformation. You've heard that orlistat can help you lose weight without surgery or injections
By Arbor Health Team

The weight-loss industry generates over $70 billion in annual revenue in the United States alone, yet the long-term success rates of most programs remain stubbornly low.
By Arbor Health Team

The scale is the most commonly used tool for tracking weight loss, and for good reason.
By Arbor Health Team

GLP-1 medications like semaglutide and tirzepatide produce remarkable weight-loss results, which are no longer in dispute.
By Arbor Health Team